Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

Clinical trial NCT01738477 · COMPLETED

Trial details

NCT number: NCT01738477
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Acellular Pertussis Diphtheria

Start date: 2013-01-31
Primary completion: 2014-04-02
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.